Fabrication of controlled-release polymeric microneedles containing progesterone-loaded self-microemulsions for transdermal delivery

References

• Alkilani AZ, McCrudden MT, Donnelly RF. 2015. Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics. 7(4):438–470. eng. doi:10.3390/pharmaceutics7040438.
   PubMed Web of Science ®Google Scholar
• Altuntaş E, Tekko IA, Vora LK, Kumar N, Brodsky R, Chevallier O, McAlister E, Kurnia Anjani Q, McCarthy HO, Donnelly RF. 2022. Nestorone nanosuspension-loaded dissolving microneedles array patch: a promising novel approach for ‘on-demand’ hormonal female-controlled peritcoital contraception. Int J Pharm. 614:121422. doi:10.1016/j.ijpharm.2021.121422.
   PubMedGoogle Scholar
• Aumklad P, Suriyaamporn P, Patrojanasophon P. 2022. Formulation and optimization of progesterone microemulsion using simplex lattice mixture design. KEM. 914:75–80. doi:10.4028/p-rj4fmr.
   Google Scholar
• Bartnikowski M, Dargaville T, Ivanovski S, Hutmacher D. 2019. Degradation mechanisms of polycaprolactone in the context of chemistry, geometry and environment. Prog Polym Sci. 96:1–20. doi:10.1016/j.progpolymsci.2019.05.004.
   Web of Science ®Google Scholar
• Bhatnagar S, Gadeela PR, Thathireddy P, Venuganti VVK. 2019. Microneedle-based drug delivery: materials of construction. J Chem Sci. 131(9):90. doi:10.1007/s12039-019-1666-x.
   Web of Science ®Google Scholar
• Biruss B, Valenta C. 2008. The advantage of polymer addition to a non-ionic oil in water microemulsion for the dermal delivery of progesterone. Int J Pharm. 349(1–2):269–273. doi:10.1016/j.ijpharm.2007.08.003.
   PubMed Web of Science ®Google Scholar
• Cerchiara T, Luppi B, Bigucci F, Zecchi V. 2003. Effect of chitosan on progesterone release from hydroxypropyl-beta-cyclodextrin complexes. Int J Pharm. 258(1–2):209–215. eng. doi:10.1016/s0378-5173(03)00202-3.
   PubMed Web of Science ®Google Scholar
• Chavda VP, Shah D. 2017. Chapter 25 - Self-emulsifying delivery systems: one step ahead in improving solubility of poorly soluble drugs. In: Ficai A, Grumezescu AM, editors. Nanostructures for Cancer Therapy. Amsterdam: Elsevier; p. 653–718.
   Google Scholar
• Coneac G, Vlaia V, Olariu I, Muţ AM, Anghel DF, Ilie C, Popoiu C, Lupuleasa D, Vlaia L. 2015. Development and evaluation of new microemulsion-based hydrogel formulations for topical delivery of fluconazole. AA P S. 16(4):889–904. eng. doi:10.1208/s12249-014-0275-8.
   Google Scholar
• Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, Khorasani S, Mozafari MR. 2018. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 10(2):57. eng. doi:10.3390/pharmaceutics10020057.
   PubMed Web of Science ®Google Scholar
• Dokania S, Joshi AK. 2015. Self-microemulsifying drug delivery system (SMEDDS) – challenges and road ahead. Drug Deliv. 22(6):675–690. doi:10.3109/10717544.2014.896058.
   PubMed Web of Science ®Google Scholar
• Du JY, Sanchez P, Kim L, Azen CG, Zava DT, Stanczyk FZ. 2013. Percutaneous progesterone delivery via cream or gel application in postmenopausal women: a randomized cross-over study of progesterone levels in serum, whole blood, saliva, and capillary blood. Menopause. 20(11):1169–1175. doi:10.1097/GME.0b013e31828d39a2.
   PubMed Web of Science ®Google Scholar
• Eid A, El Enshasy H, Aziz R, Elmarzugi N. 2014. The preparation and evaluation of self-nanoemulsifying systems containing Swietenia oil and an examination of its anti-inflammatory effects. Int J Nanomedicine. 9:4685–4695. doi:10.2147/IJN.S66180.
   PubMed Web of Science ®Google Scholar
• El Maghraby GM. 2010. Self-microemulsifying and microemulsion systems for transdermal delivery of indomethacin: effect of phase transition. Colloids Surf B Biointerfaces. 75(2):595–600. doi:10.1016/j.colsurfb.2009.10.003.
   PubMed Web of Science ®Google Scholar
• Goldštajn M, Mikuš M, Ferrari FA, Bosco M, Uccella S, Noventa M, Török P, Terzic S, Laganà AS, Garzon S. 2022. Effects of transdermal versus oral hormone replacement therapy in postmenopause: a systematic review. Arch Gynecol Obstet. 307(6):1727–1745. doi:10.1007/s00404-022-06647-5.
   PubMed Web of Science ®Google Scholar
• Gorzelanny C, Mess C, Schneider SW, Huck V, Brandner JM. 2020. Skin barriers in dermal drug delivery: which barriers have to be overcome and how can we measure them? Pharmaceutics. 12(7):684. eng. doi:10.3390/pharmaceutics12070684.
   PubMed Web of Science ®Google Scholar
• Hermann AC, Nafziger AN, Victory J, Kulawy R, Rocci ML, Jr, Bertino Jr JS. 2005. Over-the-counter progesterone cream produces significant drug exposure compared to a food and drug administration-approved oral progesterone product. J Clin Pharmacol. 45(6):614–619. doi:10.1177/0091270005276621.
   PubMed Web of Science ®Google Scholar
• Heylings JR, Davies DJ, Burton R. 2018. Dermal absorption of testosterone in human and pig skin in vitro. Toxicol in Vitro. 48:71–77. eng. doi:10.1016/j.tiv.2017.12.014.
   PubMed Web of Science ®Google Scholar
• Jaiswal P, Aggarwal G, Harikumar SL, Singh K. 2014. Development of self-microemulsifying drug delivery system and solid-self-microemulsifying drug delivery system of telmisartan. Int J Pharm Investig. 4(4):195–206. eng. doi:10.4103/2230-973X.143123.
   PubMedGoogle Scholar
• Jamaledin R, Makvandi P, Yiu CKY, Agarwal T, Vecchione R, Sun W, Maiti TK, Tay FR, Netti PA. 2020. Engineered microneedle patches for controlled release of active compounds: recent advances in release profile tuning. Advanced Therapeutics. 3(12):2000171. doi:10.1002/adtp.202000171.
   Google Scholar
• Javadzadeh Y, Jafari-Navimipour B, Nokhodchi A. 2007. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine). Int J Pharm. 341(1-2):26–34. eng. doi:10.1016/j.ijpharm.2007.03.034.
   PubMedGoogle Scholar
• Kamal MM, Nazzal S. 2018. Development of a new class of sulforaphane-enabled self-emulsifying drug delivery systems (SFN-SEDDS) by high throughput screening: a case study with curcumin. Int J Pharm. 539(1–2):147–156. doi:10.1016/j.ijpharm.2018.01.045.
   PubMedGoogle Scholar
• Kathe K, Kathpalia H. 2017. Film forming systems for topical and transdermal drug delivery. Asian J Pharm Sci. 12(6):487–497. eng. doi:10.1016/j.ajps.2017.07.004.
   PubMed Web of Science ®Google Scholar
• L'Hermite M. 2013. HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT. Climacteric. 16 (1):44–53. eng.
   PubMedGoogle Scholar
• Laracuente M-L, Yu MH, McHugh KJ. 2020. Zero-order drug delivery: state of the art and future prospects. J Control Release. 327:834–856. doi:10.1016/j.jconrel.2020.09.020.
   PubMed Web of Science ®Google Scholar
• Larrañeta E, Moore J, Vicente-Pérez EM, González-Vázquez P, Lutton R, Woolfson AD, Donnelly RF. 2014. A proposed model membrane and test method for microneedle insertion studies. Int J Pharm. 472(1-2):65–73. doi:10.1016/j.ijpharm.2014.05.042.
   PubMedGoogle Scholar
• Lee JW, Park JH, Prausnitz MR. 2008. Dissolving microneedles for transdermal drug delivery. Biomaterials. 29(13):2113–2124. eng. doi:10.1016/j.biomaterials.2007.12.048.
   PubMed Web of Science ®Google Scholar
• Lee Y, Li W, Tang J, Schwendeman SP, Prausnitz MR. 2021. Immediate detachment of microneedles by interfacial fracture for sustained delivery of a contraceptive hormone in the skin. J Control Release. 337:676–685. eng. doi:10.1016/j.jconrel.2021.08.012.
   PubMed Web of Science ®Google Scholar
• Lopes LB, Murphy N, Nornoo A. 2009. Enhancement of transdermal delivery of progesterone using medium-chain mono and diglycerides as skin penetration enhancers. Pharm Dev Technol. 14(5):524–529. doi:10.1080/10837450902814180.
   PubMed Web of Science ®Google Scholar
• Lu GW, Gao P. 2010. CHAPTER 3 - Emulsions and microemulsions for topical and transdermal Drug Delivery. In: Kulkarni VS, editor. Handbook of non-invasive drug delivery systems. Boston: William Andrew Publishing; p. 59–94.
   Google Scholar
• Mandić J, Zvonar Pobirk A, Vrečer F, Gašperlin M. 2017. Overview of solidification techniques for self-emulsifying drug delivery systems from industrial perspective. Int J Pharm. 533(2):335–345. eng. doi:10.1016/j.ijpharm.2017.05.036.
   PubMedGoogle Scholar
• Mueck AO. 2012. Postmenopausal hormone replacement therapy and cardiovascular disease: the value of transdermal estradiol and micronized progesterone. Climacteric. 15 Suppl 1(sup1):11–17. eng. doi:10.3109/13697137.2012.669624.
   PubMedGoogle Scholar
• Naik A, Kalia YN, Guy RH. 2000. Transdermal drug delivery: overcoming the skin’s barrier function. Pharm Sci Technol Today. 3(9):318–326. eng. doi:10.1016/s1461-5347(00)00295-9.
   PubMedGoogle Scholar
• Nepal PR, Han HK, Choi HK. 2010. Preparation and in vitro-in vivo evaluation of Witepsol H35 based self-nanoemulsifying drug delivery systems (SNEDDS) of coenzyme Q(10). Eur J Pharm Sci. 39(4):224–232. eng. doi:10.1016/j.ejps.2009.12.004.
   PubMed Web of Science ®Google Scholar
• Nowak E, Kovalchuk NM, Che Z, Simmons MJH. 2016. Effect of surfactant concentration and viscosity of outer phase during the coalescence of a surfactant-laden drop with a surfactant-free drop. Colloids Surf, A. 505:124–131. doi:10.1016/j.colsurfa.2016.02.016.
   Google Scholar
• Park JH, Allen MG, Prausnitz MR. 2006. Polymer microneedles for controlled-release drug delivery. Pharm Res. 23(5):1008–1019. eng. doi:10.1007/s11095-006-0028-9.
   PubMed Web of Science ®Google Scholar
• Patel M, Patel R. 2019. Linagliptin loaded Solid-SMEEDS for enhanced solubility and dissolution: formulation development and optimization by D-optimal design. J Drug Delivery Ther. 9(2):47–56. doi:10.22270/jddt.v9i2.2465.
   Google Scholar
• Pouton CW. 2000. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying’ drug delivery systems. Eur J Pharm Sci. 11 Suppl 2(Suppl 2):S93–S98. eng. doi:10.1016/s0928-0987(00)00167-6.
   PubMedGoogle Scholar
• Prior JC. 2018. Progesterone for treatment of symptomatic menopausal women. Climacteric. 21(4):358–365. doi:10.1080/13697137.2018.1472567.
   PubMed Web of Science ®Google Scholar
• Rathore C, Hemrajani C, Sharma AK, Gupta PK, Jha NK, Aljabali AAA, Gupta G, Singh SK, Yang J-C, Dwivedi RP, et al. 2023. Self-nanoemulsifying drug delivery system (SNEDDS) mediated improved oral bioavailability of thymoquinone: optimization, characterization, pharmacokinetic, and hepatotoxicity studies. Drug Deliv Transl Res. 13(1):292–307. doi:10.1007/s13346-022-01193-8.
   PubMed Web of Science ®Google Scholar
• Saraswathy K, Agarwal G, Srivastava A. 2020. Hyaluronic acid microneedles-laden collagen cryogel plugs for ocular drug delivery. J Appl Polymer Sci. 137(42):49285. doi:10.1002/app.49285.
   Web of Science ®Google Scholar
• Septiyanti M, Meliana Y, Aiman S, Ghozali M, Triwulandari E, Putri R. 2018. Formulation of palm oil based surfactant for fungicide emulsifiable concentrate. International Symposium on Innovative Bio-Production Indonesia; 2018 Nov 1; Bogor, Indonesia.
   Google Scholar
• Sheshala R, Anuar NK, Abu Samah NH, Wong TW. 2019. In vitro drug dissolution/permeation testing of nanocarriers for skin application: a comprehensive review. AAPSci. 20(5):164. eng.
   Google Scholar
• Simon GA, Maibach HI. 2000. The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations–an overview. Skin Pharmacol Appl Skin Physiol. 13(5):229–234. eng. doi:10.1159/000029928.
   PubMedGoogle Scholar
• A S, Nm S, Cb P, Rk K, V VN. 2020. Micro emulsions: an Overview And Pharmaceutical Applications. World J Curr Med Pharm Res. 2(2):201–205.
   Google Scholar
• Stanczyk FZ. 2014. Treatment of postmenopausal women with topical progesterone creams and gels: are they effective? Climacteric. 17 Suppl 2(sup2):8–11. doi:10.3109/13697137.2014.944496.
   PubMedGoogle Scholar
• Stevenson JC, Crook D, Godsland IF, Lees B, Whitehead MI. 1993. Oral versus transdermal hormone replacement therapy. Int J Fertil Menopausal Stud. 38Suppl (1):30–35. eng.
   PubMedGoogle Scholar
• Suriyaamporn P, Opanasopit P, Ngawhirunpat T, Rangsimawong W. 2021. Computer-aided rational design for optimally Gantrez® S-97 and hyaluronic acid-based dissolving microneedles as a potential ocular delivery system. J Drug Delivery Sci Technol. 61:102319. doi:10.1016/j.jddst.2020.102319.
   Web of Science ®Google Scholar
• Suriyaamporn P, Opanasopit P, Ngawhirunpat T, Rangsimawong W. 2022. Development and evaluation of a fast dissolving effervescent microneedles patch for transdermal application. Sci, Eng Health Stud. 16:22050010.
   Google Scholar
• Suriyaamporn P, Opanasopit P, Rangsimawong W, Ngawhirunpat T. 2022. Optimal design of novel microemulsions-based two-layered dissolving microneedles for delivering fluconazole in treatment of fungal eye infection. Pharmaceutics. 14(3):472. doi:10.3390/pharmaceutics14030472.
   PubMed Web of Science ®Google Scholar
• Suriyaamporn P, Rangsimawong W, Opanasopit P, Ngawhirunpat T. 2020. Development and Characterization of Gantrez® S-97 and Hyaluronic Acid Microneedles for Transdermal Fluorescein Sodium Delivery. KEM. 859:125–131. doi:10.4028/www.scientific.net/KEM.859.125.
   Google Scholar
• Tekko IA, Chen G, Domínguez-Robles J, Thakur RRS, Hamdan IMN, Vora L, Larrañeta E, McElnay JC, McCarthy HO, Rooney M, et al. 2020. Development and characterisation of novel poly (vinyl alcohol)/poly (vinyl pyrrolidone)-based hydrogel-forming microneedle arrays for enhanced and sustained transdermal delivery of methotrexate. Int J Pharm. 586:119580. doi:10.1016/j.ijpharm.2020.119580.
   PubMed Web of Science ®Google Scholar
• Ujhelyi Z, Vecsernyés M, Fehér P, Kósa D, Arany P, Nemes D, Sinka D, Vasvári G, Fenyvesi F, Váradi J, et al. 2018. Physico-chemical characterization of self-emulsifying drug delivery systems. Drug Discov Today Technol. 27:81–86. eng. doi:10.1016/j.ddtec.2018.06.005.
   PubMedGoogle Scholar
• Valenta C, Biebel R. 1998. In vitro release study of transdermal delivery systems of progesterone. Drug Dev Ind Pharm. 24(2):187–191. eng. doi:10.3109/03639049809085606.
   PubMed Web of Science ®Google Scholar
• van Staden D, Du Plessis J, Viljoen J. 2020. Development of topical/transdermal self-emulsifying drug delivery systems, not as simple as expected. Sci Pharm. 88(2):17. doi:10.3390/scipharm88020017.
   Web of Science ®Google Scholar
• Vinarov Z, Dobreva P, Tcholakova S. 2018. Effect of surfactant molecular structure on progesterone solubilization. J Drug Delivery Sci Technol. 43:44–49. doi:10.1016/j.jddst.2017.09.014.
   Web of Science ®Google Scholar
• Waghule T, Singhvi G, Dubey SK, Pandey MM, Gupta G, Singh M, Dua K. 2019. Microneedles: a smart approach and increasing potential for transdermal drug delivery system. Biomed Pharmacother. 109:1249–1258. doi:10.1016/j.biopha.2018.10.078.
   PubMed Web of Science ®Google Scholar
• Wang SH, Zhang LC, Lin F, Sa XY, Zuo JB, Shao QX, Chen GS, Zeng S. 2005. Controlled release of levonorgestrel from biodegradable poly(D,L-lactide-co-glycolide) microspheres: in vitro and in vivo studies. Int J Pharm. 301(1-2):217–225. eng. doi:10.1016/j.ijpharm.2005.05.038.
   PubMedGoogle Scholar
• Wang T, Wang R, Chen Z, Zhong Q. 2017. Magnetization of eugenol to fabricate magnetic-responsive emulsions for targeted delivery of caffeic acid phenethyl ester. R Soc Chem Adv. 7(69):43455–43463. doi:10.1039/C7RA08167G.
   Web of Science ®Google Scholar
• Wong BS, Teoh SH, Kang L. 2012. Polycaprolactone scaffold as targeted drug delivery system and cell attachment scaffold for postsurgical care of limb salvage. Drug Deliv Transl Res. 2(4):272–283. eng. doi:10.1007/s13346-012-0096-9.
   PubMed Web of Science ®Google Scholar
• Xi J, Chang Q, Chan CK, Meng ZY, Wang GN, Sun JB, Wang YT, Tong HH, Zheng Y. 2009. Formulation development and bioavailability evaluation of a self-nanoemulsified drug delivery system of oleanolic acid. AAPharm Sci. 10(1):172–182. eng. doi:10.1208/s12249-009-9190-9.
   Google Scholar
• Yalkowsky SH, He Y, Jain P. 2016. Handbook of aqueous solubility data. Bioscience, Physical Sciences. 2nd ed. Boca Raton: CRC Press, 2010.
   Google Scholar
• Zupančič O, Rohrer J, Thanh Lam H, Grießinger JA, Bernkop-Schnürch A. 2017. Development and in vitro characterization of self-emulsifying drug delivery system (SEDDS) for oral opioid peptide delivery. Drug Dev Ind Pharm. 43(10):1694–1702. eng. doi:10.1080/03639045.2017.1338722.
   PubMed Web of Science ®Google Scholar